These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 15204421)
1. The potentially curable prostate cancer patient and the pathways leading to diagnosis and treatment. Gjengstø P; Eide J; Frugård J; Bakke A; Høisaeter PA Scand J Urol Nephrol; 2004; 38(1):15-8. PubMed ID: 15204421 [TBL] [Abstract][Full Text] [Related]
2. [The general practitioner's part in the initiation of diagnostic procedures in prostate cancer]. Braun KP; May M; Grassmel Y; Führer S; Hoschke B; Braun V Aktuelle Urol; 2008 Mar; 39(2):141-6. PubMed ID: 18379968 [TBL] [Abstract][Full Text] [Related]
3. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark. Jønler M; Eddy B; Poulsen J Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092 [TBL] [Abstract][Full Text] [Related]
4. [The assessment of pathological PSA values by the general practitioner--observation or intervention?]. Braun KP; Brookman-Amissah S; May M; Grassmel Y; Hoschke B; Braun V Aktuelle Urol; 2009 May; 40(3):171-4. PubMed ID: 19479670 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum markers for prostate cancer. Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759 [TBL] [Abstract][Full Text] [Related]
6. [One man of five aged 50 years and over referred to a urologist is diagnosed with cancer. PSA analysis is important for correct prioritization of the referrals]. Boman H; Hedelin H Lakartidningen; 2005 May 16-22; 102(20):1519-21. PubMed ID: 15973877 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985 [TBL] [Abstract][Full Text] [Related]
8. Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry. Stattin P; Johansson R; Damber JE; Hellström M; Hugosson J; Lundgren R; Varenhorst E; Johansson JE Scand J Urol Nephrol; 2003; 37(6):461-5. PubMed ID: 14675917 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of prostate specific antigen testing for prostate cancer in elderly men. Dyche DJ; Ness J; West M; Allareddy V; Konety BR J Urol; 2006 Jun; 175(6):2078-82. PubMed ID: 16697807 [TBL] [Abstract][Full Text] [Related]
10. Screening for prostate cancer: updated experience from the Tyrol study. Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158 [TBL] [Abstract][Full Text] [Related]
11. [PSA: the difficult position of general practitioners between patients and urologists]. Vincendeau S; Abi Moussa M; Manunta A; Patard JJ; Guillé F; Lobel B Prog Urol; 2003 Apr; 13(2):252-5. PubMed ID: 12765060 [TBL] [Abstract][Full Text] [Related]
12. The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK. Mokete M; Shackley DC; Betts CD; O'Flynn KJ; Clarke NW BJU Int; 2006 Feb; 97(2):266-9. PubMed ID: 16430626 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men. Agalliu I; Weiss NS; Lin DW; Stanford JL Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982 [TBL] [Abstract][Full Text] [Related]
14. Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy. D'Amico A BJU Int; 2007 Jan; 99 Suppl 1():13-6; discussion 17-8. PubMed ID: 17229162 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer and prostate-specific antigen (PSA) screening in Austria. Vutuc C; Schernhammer ES; Haidinger G; Waldhör T Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of prostate cancer detected by digital rectal examination only. Okotie OT; Roehl KA; Han M; Loeb S; Gashti SN; Catalona WJ Urology; 2007 Dec; 70(6):1117-20. PubMed ID: 18158030 [TBL] [Abstract][Full Text] [Related]
18. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years. Lilja H; Ulmert D; Björk T; Becker C; Serio AM; Nilsson JA; Abrahamsson PA; Vickers AJ; Berglund G J Clin Oncol; 2007 Feb; 25(4):431-6. PubMed ID: 17264339 [TBL] [Abstract][Full Text] [Related]
19. Prognostic features in men who died of prostate cancer. Thompson KE; Hernández J; Canby-Hagino ED; Troyer D; Thompson IM J Urol; 2005 Aug; 174(2):553-6; discussion 556. PubMed ID: 16006890 [TBL] [Abstract][Full Text] [Related]
20. Are doctors examining prostates in university hospital? Lim CH; Quinlan DM Urology; 2007 Nov; 70(5):843-5. PubMed ID: 18068436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]